<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69-ijms-22-00634">
 <label>69.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ohno</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sumiyoshi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hashine</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Shirato</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kyo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Inoue</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Phase I clinical study of the dietary supplement, 
   <italic>Agaricus blazei</italic> Murill, in cancer patients in remission
  </article-title>
  <source>Evid. Based Complementary Altern. Med.</source>
  <year>2011</year>
  <volume>2011</volume>
  <pub-id pub-id-type="doi">10.1155/2011/192381</pub-id>
 </element-citation>
</ref>
